ELAN Corporation and DuPont Merck Pharmaceutical Company have announced an alliance to co-promote their leading Parkinson's disease drugs in the US.
The alliance will be implemented by the sales force of Elan's wholly-owned subsidiary, Athena Neurosciences and DuPont Merck. The products are Permax and Sinemet CR.
Join The Irish Times on WhatsApp and stay up to date
Sign up to the Business Today newsletter for the latest new and commentary in your inbox
Listen to Inside Business podcast for a look at business and economics from an Irish perspective
Get the latest business news and commentary from our expert business team in your inbox every weekday morning
